Tag Archives: Banks

article 3 months old

CBA’s Upside Trend


 

Bottom Line 19/03/14

Daily Trend: Up
Weekly Trend: Down
Monthly Trend: Up

Technical Discussion

We were asking the question last time regarding Commonwealth Bank ((CBA)) whether a 3-wave movement had drawn to a conclusion which if correct was a very bullish proposition indeed.  However, price has basically meandered sideways since that time and although not a bearish proposition we haven’t seen the impulsive move required to kick start the expected leg higher.  It could be that a little more posturing is required in this general region though for the bullish case to remain it’s important that the next significant move is to the upside.  And if we take a look back at the price action since October 2011 it’s plain to see that any dips that have materialised have been very short-lived indeed.  And to a certain extent this is a self-fulfilling prophecy with buyers waiting in the wings to jump onto the trend at any opportunity.  Although anything’s possible there is no reason to suggest why this trait is going to change anytime soon which can only mean that we need to be looking for an upside breakout.  Indeed, it would take a break beneath the early February low at $72.14 to suggest a much deeper retracement is going to unfold making it an area to keep a close eye on should weakness take hold.

The continued consolidation suggests that wave-4 is unfolding as an Elliott Triangle.  We’ve already seen the required 5-internal swings labelled (a) through-(e) although it’s by no means textbook.  Continued lacklustre price action would suggest wave-(e) is still to evolve which is more than feasible.  This wouldn’t change our wave count in any way but it would mean that the current corrective phase needs a little longer to complete.  So whether we get on with the job and break higher immediately or in a few weeks time is open for debate.  What we can say though is that a consolidation pattern forming at all-time highs coupled with the exceptionally strong longer term uptrend can only be viewed in a positive light.  So as we mentioned above all things being equal the next break should be to the upside, notwithstanding the broader market doing something untoward.  As we’ve been mentioning over the course of several months now there is no reason why the magic $100.00 level can’t be achieved over the coming months with the prerequisite being that the descending triangle breaks to the upside.

Trading Strategy

We’ve said it many times before but it’s worth repeating, consolidation patterns like pennants and triangles provide low risk entries which is something that’s always required as far as I’m concerned.  We need a logical level to place the initial stop which in this instance is the lower boundary of the triangle.  So if you’re looking for a trade in a strong trending company then CBA is putting its hand up.  Buy following a break above the upper boundary of the ascending triangle with the initial stop placed just beneath the lower trend line of the pattern.  For short term traders the target sits around the $85.00 region which is where the measured move out of the triangle sits.  Longer term the $100.00 mark is attainable as previously mentioned.
 

Re-published with permission of the publisher. www.thechartist.com.au All copyright remains with the publisher. The above views expressed are not by association FNArena's (see our disclaimer).

Risk Disclosure Statement

THE RISK OF LOSS IN TRADING SECURITIES AND LEVERAGED INSTRUMENTS I.E. DERIVATIVES, SUCH AS FUTURES, OPTIONS AND CONTRACTS FOR DIFFERENCE CAN BE SUBSTANTIAL. YOU SHOULD THEREFORE CAREFULLY CONSIDER YOUR OBJECTIVES, FINANCIAL SITUATION, NEEDS AND ANY OTHER RELEVANT PERSONAL CIRCUMSTANCES TO DETERMINE WHETHER SUCH TRADING IS SUITABLE FOR YOU. THE HIGH DEGREE OF LEVERAGE THAT IS OFTEN OBTAINABLE IN FUTURES, OPTIONS AND CONTRACTS FOR DIFFERENCE TRADING CAN WORK AGAINST YOU AS WELL AS FOR YOU. THE USE OF LEVERAGE CAN LEAD TO LARGE LOSSES AS WELL AS GAINS. THIS BRIEF STATEMENT CANNOT DISCLOSE ALL OF THE RISKS AND OTHER SIGNIFICANT ASPECTS OF SECURITIES AND DERIVATIVES MARKETS. THEREFORE, YOU SHOULD CONSULT YOUR FINANCIAL ADVISOR OR ACCOUNTANT TO DETERMINE WHETHER TRADING IN SECURITES AND DERIVATIVES PRODUCTS IS APPROPRIATE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCES.

Technical limitations If you are reading this story through a third party distribution channel and you cannot see charts included, we apologise, but technical limitations are to blame.

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Bank Of Queensland Looking Bullish

By Michael Gable 

After being down for 5 consecutive days, the Dow Jones rallied overnight on low volume. The bearish tone for the short term is still set in our opinion and the trend for the Australian market in the next few weeks is to the downside, to the point where better opportunities will present themselves. One development catching our eye is the direction of interest rates. The cash rate in New Zealand was increased last week by 0.25%. Yesterday saw Bill Evans from Westpac change their stance on interest rates from that of an easing bias. His is now predicting that rates will be on hold for the time being and the next move will be an increase. This will clearly have ramifications for stocks that have been used as a proxy for bonds, that is the appeal of the high yielding stocks will diminish somewhat. In terms of the banks, the yield is still dependable and attractive, but it will be interesting to see how valuations change over the year. On that note, we take a brief look at this while covering Bank of Queensland ((BOQ)) in more detail in today’s report. 


Bank of Queensland


We had a look at the BOQ chart as recently as 18 February when it was trading at $12.04, and we commented that “conservative investors would like to see the previous swing high around $12.50 to be penetrated first before entering this trade. But if it does, it should go to a new high. First level of resistance around $13, but beyond that it can run towards just over $14.” It has now gone through that previous swing high and broken out of the recent downtrend. It is looking very bullish here so after cooling off in the short term, we should see BOQ at some point in the next few weeks run up towards $13 and potentially hit that $14 target, provided that markets overall behave themselves.?
 

Content included in this article is not by association the view of FNArena (see our disclaimer).
 
Michael Gable is managing Director of  Fairmont Equities (www.fairmontequities.com)

Michael assists investors to achieve their goals by providing advice ranging from short term trading to longer term portfolio management, deals in all ASX listed securities and specialises in covered call writing to help long term investors protect their share portfolios and generate additional income.

Michael is RG146 Accredited and holds the following formal qualifications:

• Bachelor of Engineering, Hons. (University of Sydney) 
• Bachelor of Commerce (University of Sydney) 
• Diploma of Mortgage Lending (Finsia) 
• Diploma of Financial Services [Financial Planning] (Finsia) 
• Completion of ASX Accredited Derivatives Adviser Levels 1 & 2

Disclaimer

Michael Gable is an Authorised Representative (No. 376892) and Fairmont Equities Pty Ltd is a Corporate Authorised Representative (No. 444397) of Novus Capital Limited (AFS Licence No. 238168). The information contained in this report is general information only and is copy write to Fairmont Equities. Fairmont Equities reserves all intellectual property rights. This report should not be interpreted as one that provides personal financial or investment advice. Any examples presented are for illustration purposes only. Past performance is not a reliable indicator of future performance. No person, persons or organisation should invest monies or take action on the reliance of the material contained in this report, but instead should satisfy themselves independently (whether by expert advice or others) of the appropriateness of any such action. Fairmont Equities, it directors and/or officers accept no responsibility for the accuracy, completeness or timeliness of the information contained in the report.

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Australian Banks: The New Defensives

By Greg Peel

When FNArena last took a look at the Australian banks, before the results and update season just passed (Australian Banks: The Outlook For 2014), the ASX Financials Ex-REITs index (XXJ) was tracking below the ASX 200 (XJO) due to a renewed interest in higher risk, cyclical exposures, including resources, and analyst warnings the Big Banks were looking rather well valued. The XXJ has continued to track below the XJO but in lock-step through February and right up to this week when the iron ore price plunge sent investors high-tailing out of the miners.

It must be noted the banks have an in-built safety net in the form of their fully-franked dividend yields which imply a floor price in any weakness. The Big Four spent 2014 handing out capital returns like candy. But it is that candy which has thrown up an interesting conundrum for the big lenders, and thus investors, in 2014.

2013 was been another year in which the banks wound down provisions put in place after the GFC to cover the rush of bad debts expected at the time, as well as to cover more general market risk in that volatile period. Default levels were not quite as bad as expected and as each year has gone by, the number of bad and doubtful debts on bank balance sheets has quietly reduced, thus reducing the need for said provisions.

Provisions were originally set aside from retained earnings so when no longer needed they come back onto the earnings line to add to earnings generated from actual business. The banks then decide what to do with this capital. Under normal circumstances there’s little doubt – capital must be allocated as backing to new loans the bank is providing to customers and shareholders must be paid out their share. The thing is, though, the banks are writing very little new business. If there’s very little new business to write, requiring capital deployment, then there’s a lot of money sitting around that might as well be used to keep shareholders happy and to look good at a time yield is highly sought after.

Hence the candy, in the form of dividend payout ratio increases, special dividends, and neutralised dividend reinvestment plans (DRP), meaning no shareholder dilution. But now comes the twist.

If credit demand in Australia does start to pick up, then while bank earnings forecasts will rise, so will the draw on bank capital as backing for these new loans. Broker views vary, but there is a feeling the post-GFC provision reduction period has now run its course, meaning “earnings” distributed as dividends will actually have to be earned through normal business. Thus, even if bank earnings do improve, there is little real possibility of the banks further extending their capital distributions. As CLSA puts it:

“Sadly the sustainability of the much increased (~75%) dividend payout ratios of the Australian banks is a function of the prevailing low loan growth environment (ie less requirement to retain capital to keep capital ratios steady on a slower growing asset base)”.

So what investors might have gained on the swings they can lose on the roundabout, ironically under improved economic conditions. At the very least, this conundrum does rather imply that the days of hard-running bank share prices have likely passed, and from here on the banks will once again, for the first time in about a decade, become “defensive” stocks.

There has already been a pick-up in loan demand in recent months, as evidenced in the great property investment house price boom. Over the twelve months to January, housing lending has risen 5.6% and represents around 60% of all outstanding bank loans. There has also been a slight pick-up in business credit demand, although at 2.0% this remains in the “subdued” range. Business lending represents around 34% of outstanding loans.

[I am reminded at this point that bank analysts first began expecting a post-GFC bounce in business credit demand in 2010, or if not in 2010 then definitely in 2011. It’s 2014 and counting…]

With respect to the conundrum explained above, housing loans represent a literal “bricks & mortar” investment and as such require a lower ratio of regulatory capital backing from the lender. Business loans, on the other hand, require levels of capital ranging from more to much more depending on the risks involved. In other words, the recent rise in lending for housing is not having a lot of impact on bank capital available for dividends. When the day finally comes and business credit demand starts to take off again (and it should not be too far away in this low interest rate environment), that’s when the dividend payout dilemma will really kick in.

The low capital intensity of housing loans has allowed the banks to offer strong dividend yields and the reporting season has shown net interest margins have held up despite the competition amongst the banks for this new business, given the competition for deposits has now eased off on the other side of the margin ledger. Anyone who suggests there is no competition between the banks is either ignorant or a politician. The risk ahead is that a pick-up in business loan demand will again see the banks at each other’s throats in a higher capital intensity segment and at a time provision write-backs are done and dusted. Indeed, increased business loan books naturally imply a return to increasing provisions hence net interest margins are likely to be the victim, along with shareholders expecting more and more candy.

And not only have the regional banks and non-bank lenders re-entered the home loan fray via the resurrection of the mortgage securitisation market, previously killed off by the GFC, but the European banks have become emboldened enough to start sniffing around Australia’s business lending market once more.

Zombies attack.

The wash-up from the interim report and quarterly update season is that the banks have performed reasonably well and in line with expectations. Net interest margins, as noted, have held up, rising costs have been kept under control with discipline and wealth management businesses have found a new lease of life on the back of the rising stock market. Provision write-backs have been converted into shareholder candy. Some proportion of profit has nevertheless been of lower “quality”, with Commonwealth Bank ((CBA)) in particular enjoying a lift in market trading profits (which are volatile) and currency benefits.

Westpac ((WBC)) has made a concerted push back into mortgage lending after shying away for a couple of years while between the two smaller Big Banks, National Bank ((NAB)) is closer to finally exiting its disastrous UK foray and can look forward to provision write-backs from offshore (NAB has been a bit behind in the candy race), while ANZ Bank’s ((ANZ)) offshore push has potentially turned from bonus to drag as Fed tapering threatens emerging market currencies.

As far as current bank share price valuations are concerned, BA-Merrill Lynch points out the carry trade is “alive and well” and can only thrive on falling volatility. The “carry trade” is a reference to offshore investors, such as in the US, who can borrow funds at very low rates of interest and invest in AA-rated Australian banks for a 5-6% yield (no franking, but a big spread anyway). The lower the volatility of the general market, the less likely those investors will do their dough on a fall in share price, and/or a collapse in the Aussie dollar. The carry trade harks back to the earlier suggestion the banks offer a natural safety net in the form of their dividend yields.

Volatility markedly reduced over 2013 as the ghosts of the GFC appeared to all but fade away. Of course it doesn’t take much (see: China, Cold War II) to bring it back.

Prior to February the only bank appearing to be "overvalued" against the consensus target price of FNArena database brokers was CBA, but then CBA is almost perennially "overvalued". The biggest Big Bank is consistently awarded a premium over the other banks, including close rival Westpac, and despite years of analyst insistence that premium gap must close, it never actually has. So we can take CBA "overvaluation" with a grain of salt, but we can pay attention to history and note the market tends to lose interest in CBA once its gone ex-dividend (February and August), preferring to anticipate fresh capital management announcements from the other three (May, November).

The following table is updated based on yesterday's closing prices. As we can see, CBA retains its fourth preference position with no Buy or equivalent ratings from FNArena brokers and a target price sitting 2.93% below the trading the price. But we also see Westpac has now joined CBA in the "overvalued" camp. ANZ and NAB both show plenty of upside potential between them, largely suggesting analysts are more confident than the market at present. ANZ's exposure to Asia is acting as a drag given fears over Chinese slowing and the aforementioned impact of Fed tapering on emerging market currencies and bond rates. NAB has for a long time now carried a "UK discount", and despite the outlook appearing a lot more positive in the UK the market is yet to give NAB the benefit of the doubt.
 


Indeed, while it is likely the other three banks have used up most of their candy fire power for now (we note CBA disappointed at its recent result, although Westpac may yet have a little left to sweeten the pot), NAB was unable to match its rivals last year given its UK risk overhang. But with the UK economy firing on all cylinders, and the British government having begun the process of divesting of its 2008 "bail out" equity in the UK majors, it may well be possible NAB can reconsider a sale of its UK assets. Notwithstanding a sale, the reduction in risk in NAB's bad and doubtful UK loan book suggests provisions can now be written back and taken as earnings. Hence of all the Big Four, NAB has the only real potential to provide increased distributions in the next year or two.

Yet the market continues to apply a risk discount in pricing NAB. It's largely a "once bitten" hangover.

As the table shows, all four banks continue to offer 5-6% yields before franking. This is safety net territory, as indeed was evident yesterday on the Australian market when the buyers galloped in later in the day after the morning saw a China-related capitulation in bank stocks.

Yield support, but no great distribution upside potential from here, a subdued earnings growth outlook, and a tit-for-tat trade off in distribution capital against operating capital if credit demand picks up and translates into a brighter earnings outlook.

There will be some in the market who won't recall the days when bank stocks were considered "defensive". In 2007, when the GFC will still but a young Credit Crunch, bank analyst after bank analyst assured investors there was nothing to fear given bank stocks are "defensive" and always hold up in volatile markets. They were proven very, very wrong and indeed, naive. Over five years on, they might now be right.


Technical limitations

If you are reading this story through a third party distribution channel and you cannot see charts included, we apologise, but technical limitations are to blame.

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Insurers On A Tight Rope

-Growth targets too optimistic?
-Large players losing share
-Wealth management most positive
 

By Eva Brocklehurst

The ability to balance sluggish fundamentals against ambitious growth targets is central to the 2014 investment case for insurers. UBS thinks so. Insurers expect to grow gross written premiums (GWP) by around 6-7% in 2014, which to UBS seems reasonable based on long-run growth rates. Still, this does imply an acceleration in the second half. Something which the broker thinks is quite optimistic in a soft pricing cycle. Is there enough premium growth to go around? Across the majors, should premiums grow at 3%, the shortfall relative to targets exceeds $500m, a big ask in UBS' opinion.

Credit Suisse observes the recent reporting season had investors trying to pick the insurance cycle for general insurers. The broker suspects a pricing peak is nigh. Underlying margins improved in the December half but the broker notes, despite improving profitability, the focus was on the slowing of GWP. The three largest Australian general insurers, Insurance Australia Group ((IAG)), Suncorp ((SUN)) and QBE Insurance ((QBE)) all underperformed over the past three months. Credit Suisse takes a view that QBE's earnings recovery will continue, but the road will be rocky. The broker finds the valuation undemanding and has an Outperform rating. IAG is awaiting approval for the acquisition of the underwriting business from Wesfarmers ((WES)) and the broker thinks this may hold the stock back in the near term, so a Neutral rating is maintained. Suncorp was upgraded to Neutral by the broker after its result in February as earnings have now re-based and the downside risk is reduced.

Insurer trading multiples are attractive, Morgan Stanley concedes. Suncorp is targeting 7-9% growth and IAG 3-5%, but the broker thinks it more likely they will grow at less than GDP. The broker is comforted by IAG's more conservative target. Morgan Stanley also observes margins remain strong but slower top line growth will dampen the earnings outlook. The broker believes the listed players are lagging the market. Suncorp's and IAG's large share in the Victorian property market hurt relative growth in the December half but even adjusting for this, they are still lagging. Morgan Stanley compares growth of 1.4% and 1.1% respectively in the December half comparing this with system growth of 5.7%. QBE compares more favourably with 3.4% but that includes New Zealand.

Cutting out two distractions to the thesis - the Victorian Fire Service Levy and NZ dollar - UBS believes it is beyond dispute that the majors, particularly Suncorp and IAG, continue to lose share. Outside of the five majors, others grew at 11.5% in the December half, materially higher than the market at 6% and more than twice the 4% growth rate achieved by the five majors. UBS concurs that IAG appears to have the least aspirational, or perhaps most realistic, target. The broker maintains that sub 5% growth may seem bearish but it is not unlikely in a soft commercial market where claims inflation is benign. The broker observes the two major domestic general insurers have managed pricing and margins well since early 2011. Still, it's a delicate balance between premium growth and margins.

Suncorp is the stand-out for UBS, given its capital return initiatives, but a marginal preference is retained for IAG given recent price moves. UBS has a Neutral rating for both Suncorp and IAG. Valuations are now more compelling but the broker is cautious, given the likely tipping point for the price cycle. QBE offers most upside and UBS rates the stock a Buy.

UBS has noticed life insurance trends are stabilising and individual in-force growth for the three largest in this market - AMP ((AMP)), Commonwealth Bank ((CBA)) and National Australia Bank ((NAB)) - has now fallen to 2-4%, as re-pricing is balanced against the risk of further aggravating high lapses. With the exception of Suncorp, all others are growing in-force at above the industry average of 9.1%. This growth rate for "others" highlights for UBS the switching nature of many policy lapses and the impact of ongoing price pressure. Moreover, total new business may have been up 48% in the December quarter but this was driven by two large mandate changes. In the individual market, sales stagnated. AMP's individual rate slowed to 4.3% from 7.3% over 2013 and the broker thinks the stock will struggle to generate material in-force growth given the insurer said at the results briefing that lapses would continue at a "shock" level before improving.

Morgan Stanley prefers the wealth managers over the domestic insurers as there's more upside for earnings, supportive markets and regulatory tailwinds. Fourth quarter statistics showed a continued recovery in fund flows with growth now at levels that UBS thinks could be considered normal for the current stage of superannuation evolution. 2014 is shaping up as the first year for some time where fund flows could positively surprise. Life earnings risk is now manageable from a group perspective for AMP and UBS thinks that company's ability to attract considerable and meaningful flows will support wealth management earnings. AMP's funds under management growth of 6.4% in the December quarter places it at the top of the peer ladder but this was at least half driven by acquisitive growth in self managed super funds. UBS thinks, as positive sentiment continues, a 3% flow growth assumption for AMP is achievable.
 

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Weekly Broker Wrap: Telcos, REITs, Registries, Wagering And Media

-Growth slowing for telcos
-Valuation key to GPT, Charter Hall
-Shareholder numbers decreasing
-William Hill threat to retail wagering
-Media outlook improving


By Eva Brocklehurst

CIMB contends there's no such thing as normal in the telco sector. Conditions change with the seasons. Still, the broker notes several abnormal issues influenced performance over the recent reporting period and these seem to be diminishing. The broker thinks the mobile sector is promising more competition, while organic growth in broadband is slowing and there are fewer acquisitions available to improve scale. Telstra ((TLS)) is well priced and offers reliable earnings and dividend with sheer scale enabling it to withstand market conditions. Smaller telcos are priced for growth or acquisitions, opportunities that CIMB thinks are receding. Growth will still happen, the broker maintains, but it will be a return to low service revenue growth in mobile and a maturing, hence slowing, of fixed broadband growth. The broker is generally neutral on the sector. Among the Aussie telcos the broker covers, CIMB has a Hold rating on Telstra and a Reduce rating for both M2 Telecommunications ((MTU)) and iiNet ((IIN)).

Are GPT Group ((GPT)) and Charter Hall Group ((CHC)) starting to resemble each other? That's the question CLSA is asking. Both have high growing property funds in the same three asset classes with near-identical margins. The broker notes Charter Hall has greater leverage to funds management growth while GPT's balance sheet capacity is a huge comparative advantage. So, which one gets the bigger tick? The starkest difference, CLSA observes, is in valuation.

The broker estimates the market places a 20 times earnings valuation on Charter Hall and no premium for GPT. In valuing Charter Hall, CLSA notes the company has outperformed Australian real estate investment trusts (A-REITs) by 13.4% versus 5.5% year-to-date, and is trading within 1% of the price target - $4.17. This means the stock is fair value, with the price target implying a 6% total return. Hence, the rating is downgraded to Underperform. In GPT's case, the stock has outperformed A-REITs by 10.3% year-to-date and the price target of $4.15 implies a 16.2% total return. The Outperform rating is maintained.

The JP Morgan registry survey, conducted in December and January, has found Computershare ((CPU)) and Link service 95% of the companies in the S&P/ASX200 index, although Boardroom doubled share to 4%. Of note, the rate of switching increased in 2013, with 4.6% of the market changing providers, up from 1-2% historically. There was also an increased tendency for respondents to put registry contracts out to tender.

Shareholder numbers continue to decrease, with 72% of companies reporting flat or decreasing shareholder numbers over past six months. Pricing was flat or falling, driven by, JP Morgan suspects, falling shareholder numbers, increased competition and a low number of contracts being renewed in any one year. Computershare received a higher positive response rate for performance compared with Link, but Link continues to outperform on cost. Another observation is that corporate activity was weaker for registrars in 2013 against 2012, while a stronger IPO market did not add material new shareholders. Secondary raisings decreased by 19% and the companies with a discounted dividend reinvestment plan fell to 17% from 26%.

Be warned. CIMB observes UK-based wagering business William Hill is talking up intentions for Australia. The company will land a vastly improved offering at the end of this month and intensify competition with the locals, Tabcorp Holdings ((TAH)) and Tatts ((TTS)). By the end of March William Hill will integrate Tom Waterhouse into Sportingbet and launch a new website, providing easier player registration and betting, with improved display and navigation. CIMB thinks this will have a significant impact on Australian online wagering. More so because it appears from the results season that online betting is cannibalising retail betting. William Hill is shifting its marketing mix towards online and the company expects to reach a 69:31 ratio in FY14. This leads to a lower cost per player acquired and will enable the business to continue to operate on considerably lower win margins than either of the local retail incumbents. It adds up to a loss of market share for both Tabcorp and Tatts, according to CIMB.

The latest results season was positive for the media. Finally, there are signs of improved trading and cost control. JP Morgan observes a bump up in share prices in response to the better outlook. It's early days but the broker is heartened by the improved second half outlook, with Fairfax Media ((FXJ)) being the stand out stock in that regard. Seven West Media ((SWM)) has increased TV guidance to low-to-mid single digit growth. The one area that remains subdued is regional markets, reflected in a more sober outlook for local revenue from Prime Media ((PRT)) and Southern Cross Media ((SXL)).

JP Morgan has Overweight recommendations on Carsales.com ((CRZ)), Seven West and Prime Media. Understood. The broker thinks the issues facing Carsales in new car inventory/manufacturer display are short/medium term. However, the broker is Underweight Ten Network ((TEN)) and Fairfax. The Underweight rating for Ten stems from the fact that JP Morgan thinks any rating/revenue recovery will take time and require significant reinvestment in programming. As for Fairfax, cost control and improved trading conditions are well and good but the broker is cautious about extrapolating this out too far. JP Morgan continues to believe that, excluding Domain, Fairfax lacks strong digital growth assets.
 

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

CLSA Warns About Cover-More’s Future

-Price sensitivity prevails in travel
-Internet offers easy, low barrier market entry
-Insurers likely to bypass in future

 

By Eva Brocklehurst

Broker CLSA has taken a contrary stance on recently-listed Cover-More ((CVO)). The subject of travel insurance irks the broker, which finds it a business that delivers no benefits to the consumers. Moreover, the value ascribed to the arrangers of travel insurance, from an investment perspective, creates a problem. Why? CLSA thinks it is all to do with the barriers to entry being low - easy start up for competition, the commodity being singularly price driven and the margin growth having a definite life cycle.

Cover-More is considered at the top of this cycle, the valuation rich at $1.88. Hence CLSA, not surprisingly, has a Sell rating. This goes against other evaluations of the stock. Two brokers, Macquarie and UBS, recently reflected on the stock's inaugural first half earnings and came up with Buy ratings and targets of $2.30.

Expanding on the thesis, CLSA notes price and ease of transaction are the only drivers in travel insurance. Hence, scale wins. The main contention is that Cover-More is not an insurer. The company is an arranger of insurance and makes it accessible to distribution companies which would never have thought of insurance as a source of revenue. So, Cover-More has the scale advantage at present. What CLSA's Sell rating hinges on is that, in the future, risk carriers, the actual insurers, will use the internet and combine distribution and underwriting more and more, providing a transparency that ultimately means Cover-More's model will be under pressure. Cover-More sources its Australian risk underwriting from Munich Re, with the contract to be renewed in 2018.

Travel insurance is sold mostly for going abroad. It's correlated to the Australian dollar and the relative attractiveness of domestic tourism, as well as changes in the "wellbeing factor" in CLSA's opinion. The broker thinks Cover-More will be dependent on cost reductions to maintain margins. Cover-More's model is predicated on offsetting lower spread margins with economy-of-scale savings. The broker agrees this is working now but thinks, ultimately, provides for diminishing returns.

While hailing the partnerships the company has forged with Air New Zealand and recently with Insurance Australia (((IAG)), UBS does point out that the longstanding and long-term joint venture with Flight Centre ((FLT)) poses some risks in terms of concentration. UBS estimates Flight Centre writes more than 40% of the company's insurance gross written premium. Flight Centre is expected to contribute 26% of Cover-More's earnings in FY14. As a result, profitability is highly correlated to Flight Centre's sales. From CLSA's perspective, while income may grow and new distribution partners be signed, this will increasingly be on terms which add little to the underlying margin and therefore the growth forecast is not of the quality that requires a higher price/earnings multiple.

UBS expects higher incremental returns over the next three years and has observed the fact that Cover-More lifted insurance earnings/gross written premium margin in the first half to 8.6%, suggesting the company is on track to meet, or exceed, the implied level of 9.1% in FY14 prospectus forecasts. To UBS, this signals that the company can extract benefits of operating leverage without having to pass on all incremental gains to distribution channel partners. CLSA concedes the margins are currently handsome but remains inclined to think insurers will eventually set up their own channels for distribution in the future, and consumers will be less inclined to purchase travel insurance from the arranger.

CLSA attributes little value to the company's Asian initiatives whereas UBS believes growth upside in the medium term in these under-penetrated markets is substantial. On the subject of the company's other business, the medical assistance and DTC segment, CLSA acknowledges it differentiates the company somewhat but adds a low margin business, not something that can be valued as a standalone. Macquarie disagrees. The DTC employee assistance segment could be an area of significant growth prospects, in that broker's opinion.

See also, Cover-More Delivers On Growth Promise on March 3

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Cover-More Delivers On Growth Promise

-Substantial growth upside
-Underpinned by key partnerships

 

By Eva Brocklehurst

Australia's largest travel insurer, Cover-More ((CVO)), delivered a clearly positive interim report, with brokers remarking on the momentum in both revenue and margins.

Macquarie noted all operations and segments were tracking ahead of the prospectus forecasts, and expectations. Gross written premium (GWP) rose 24%, while earnings from insurance increased 29.6%. The broker observes margin improvement featured, especially in the medical assistance segment, and reflects the investment that was undertaken to improve productivity and efficiency. The DTC employee assistance segment has secured its first corporate integrated wellness program, with forecast annualised revenue of $2m, and Macquarie thinks this area has significant growth prospects.

Results were significantly above UBS estimates and the broker has lifted FY14 forecasts by 6.1%. UBS expects higher incremental returns over the next three years, heading to above 25% from around 18%. Another important feature of the result was the lift in insurance earnings/gross written premium margin which, at 8.6%, is on track to meet, or exceed, the implied level of 9.1% from the FY14 prospectus forecasts. This improvement indicates to UBS that Cover-More can retain some benefits of operating leverage without having to pass on all incremental gains to distribution channel partners.

The Air New Zealand venture, which commenced in December, is trading ahead of expectations. UBS finds this a most pleasing outcome, with early indications that New Zealand turnover could double underscoring the company's competitive advantage.  The Australian business is performing well with the agency channel growing due to the Flight Centre ((FLT)) distribution agreement. A partnership with Insurance Australia Group ((IAG)) started recently. Brokers consider that while the initial book is not big, in terms of the access to an expanded client base there is considerable upside.

What's new? A market review of the UK travel insurance proposition has been undertaken in conjunction with Flight Centre and Macquarie hears the company is just awaiting the sign-off from Flight Centre in order to roll out of a more differentiated product and service offering.

The business generates greater volumes in the second half because of the increased northern hemisphere sales coming from Australia and New Zealand, as well as a seasonal weighting to the second half within India. UBS expects this skew will increase marginally over the coming years as Asia grows as a proportion of total GWP. A word of caution: Macquarie advises against using FY13 earnings seasonality for FY14 forecasts, given a step up in margins was already being realised in the second half of FY13. Macquarie retains a Buy rating and $2.30 price target.

UBS believes growth upside in the medium term is substantial, given the recent entry into larger under penetrated markets. The company also offers rare listed exposure to the outbound leisure travel theme in Australasia and Asia. The risks come from concentration with key distributors such as Flight Centre, volatility in the Australian currency and irrational competition that harms pricing and margin. Longer-term the underwriting arrangement with Munich Re will need to be renewed in 2018. Still, over the next three years, UBS thinks there is sufficient head room in the GWP forecast profile to allow for modest delays or lower conversion of new contracts. The broker expects compound annual growth in earnings from FY13-16 of around 16%. Beyond FY16 UBS assumes GWP growth reverts to a normalised level of over 7%. UBS has a Buy rating and $2.30 price target.

See also, Cover-More Offers Attractive Travel Insurance Exposure on February 3 2014.
 

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Weekly Broker Wrap: M2 Telecom, Health Care And Financials

-Disparities in M2 accounts
-Potential for M&A in radiology?
-Medicare reform possibilities
-Can bank impairments go lower?
-Fund managers prefer insurers

 

By Eva Brocklehurst

CLSA has reservations regarding junior telco M2 Telecomunications ((MTU)). The broker has a problem with the company's accounting methods for acquisitions, which is creating an exponential divergence between underlying and reported profit. The broker was surprised that the $203m paid for the Dodo acquisition will be wholly accounted for as goodwill. This means the value of identifiable net assets is zero. The broker compares such a method with the iiNet ((IIN)) acquisition of Westnet, where 20% of the price was booked to net assets. CLSA also observes that M2's management incentives are based on underlying earnings, not reported earnings. The exponential divergence in the accounting treatment lowers reported earnings and raises underlying earnings.

The broker admits it doesn't like the structure that gives management an incentive to grow by acquisition and gear up the balance sheet. CLSA's fundamental concerns about M2 centre on the absence of operating leverage and margin expansion, despite the numerous acquisitions. This brings into question the quality of the assets acquired. The broker also notes the relatively high leverage on the balance sheet, with twice net debt to earnings, a high ratio for a small telco. The broker also raises the red flag regarding governance issues - the former CEO and founder is still on the board and there's the link between management remuneration and absolute profit growth.

BA-Merrill Lynch observes from the latest Medicare and PBS data that radiology volumes have been stable over the last month, with volume and benefit growing at 5-6% and 6-8% respectively for almost a year. The recent acquisition of I-MED, Australia's largest radiology business, by a Swedish private equity group has re-affirmed the broker's belief that mergers and acquisitions will become the FY14 theme for the sub-sector. This is because of the appealing remuneration models. Having said that, Merrills acknowledges that both Primary Health Care ((PRY)) and Sonic Healthcare ((SHL)) have indicated they do not intend to pursue acquisitive growth in this sub-sector.

The broker believes the federal government has put the health industry on notice for an increased likelihood of reforms, particularly regarding the increase in contributions to health care costs for those who can afford and the need to modernise Medicare, given changing demographics and disease profiles. While there's nothing concrete likely to come ahead of the May budget, Merrills concludes that a lack of pricing uplift, if indexation of GP rates continues for another 12 months, means the only way Primary, the predominant bulk biller, could increase revenue would be to increase volume. Alternatively, the company could seek better monetisation of each patient with non-GP services, but this can be problematic in the broker's opinion.

Ultimately, Merrills expects Primary would maintain a bulk billing approach, reducing the potential growth on offer. If the government mandates a GP co-payment then Primary is seen as more exposed to this risk than Sonic. The broker maintains a preferential Buy rating on Sonic.

How low can bank impairment rates go? That's the question Credit Suisse is asking. Major bank asset quality improved in the December quarter, with impaired percentage credit exposures declining to 0.5%, the lowest in five years. Moreover, the 0.07% decline in the December quarter was the largest quarterly decline in the broker's time series. Business impaireds declined sequentially to 1.21% from 1.38%. Actual losses in the quarter were the lowest in five years. This may well be the bottom. The broker is cautious regarding the prospects for more moderation in bad debts.

From the fourth quarter financial fund managers survey Merrills notes respondents are still overweight on insurers compared with banks and diversified financials. The most popular overweight stocks are Suncorp ((SUN)) and National Australia Bank ((NAB)). Commonwealth Bank ((CBA)) is the most popular for underweight status, by quite a margin. The majority of respondents signalled Macquarie Group ((MQG)) had the greatest capacity to surprise on the upside, while QBE Insurance ((QBE)) was where analysts were most pessimistic.

The premium rate cycle was viewed as the key threat to insurer valuations according to 40% of respondents. Credit quality was the greatest perceived threat to bank valuations, with around 43% nominations, although margin squeeze was still a strong contender, with 29% naming that the greatest threat. Investment markets were perceived to be the greatest threat for diversified financial valuations. Most were comfortable with the capital positions of the banks and insurers. None of the respondents believed dividends were unsustainable, or that they would be cut. Perceptions of dividend growth were stronger for diversified financials. Earnings growth prospects were considered similar across sectors.
 

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Austbrokers Breaks Tradition But Brokers Content

-Seasonality stronger than expected
-Second half expected to be better
 

By Eva Brocklehurst

Insurance broker network, Austbrokers ((AUB)), broke with tradition after the first half results. There was no upgrade to forecasts. Brokers remain comfortable with the fact that, although commercial markets may be softening and acquisition prospects are less likely, the company has a solid business base to withstand the pressures.

Goldman Sachs retains a Buy rating and thinks the current multiples undervalue the stock's organic growth, acquisition prospects and the relatively low sensitivity to the economic climate. The broker liked the margin uplift from organic growth. Several factors that depressed earnings in the first half are expected to stabilise or reverse in the second half. These include a levelling off in the pace that interest rates decline, a bias to the second half for recent acquisitions, which tend to break even or generate small first half losses, and stabilising of the reduction in earnings from the weaker mining sector. The broker expects corporate costs, which were up 12% in the half, should now track business growth.

UBS, too, believes that while there is an increased skew to the second half in terms of profits, the upper end of the company's guidance for 5-10% growth remains achievable for the full year. Hence, the broker sticks with a Buy rating. The main disappointment in the first half came from the broking division, where revenue growth was outdone by expenses. UBS considers organic growth may be more challenging now in an increasingly competitive commercial market. Still, the company has consistently grown earnings at above 10% for the last several years and the broker sees no reason why this should not continue over the medium term.

Macquarie observes the seasonality in the acquisitions that were made at the end of FY13, notably InterRISK, has been greater than expected. InterRISK contributed a small loss to the interim result. The slowing in Western Australian mining activity also affected the result from one large broker, contributing to around a 4% reduction to profit growth. The recent Procare acquisition represents a move outside insurance broking and underwriting agencies but Macquarie believes the acquisition is complementary. Procare is a full workers compensation support service that will provide cross-selling opportunities for the network to clients and insurers. The $10m acquisition is expected to be around 1.5% accretive on a full year basis.

Macquarie suspects the lower interest rates, investment in corporate functions and lower profits from the WA broker will make upgrades hard to achieve but also believes, with a better second half from InterRISK, the top end of guidance can be achieved. As the business is high quality the broker is happy with an Outperform rating.

BA-Merrill Lynch is also on the Buy side and a believer  in the growth story, flagging the company's history of conservative guidance. The broker expects both InterRISK and Procare should contribute to improvement in the second half. Merrills likes the Austbrokers business and finds it quite resilient, despite the risks from competition and the economic cycle. There are headwinds, of course - lower cash rates and flat or falling premium rates, as well as a higher expense base. Still, the broker thinks the proven business model will prevail.

There are three Buy ratings on the FNArena database with the consensus price target of $11.78 suggesting 10.3% upside to the last share price. This compares with $11.49 ahead of the results. Targets range from $11.60 to $12.00.
 

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.

article 3 months old

Is It Yet Safe To Buy AMP?

- AMP' wealth management result will be strong
- AMP's wealth protection division will kill the party
- AMP's share price has significantly de-rated
- Is the bottom in place?


By Greg Peel

2013 was a great year for Australian stocks, with fortunes noticeably picking up from July. As a company, if one of your major businesses is wealth management then you should reasonably have expected to have also had a good year in terms of earnings growth and share price appreciation. Unless you’re the AMP ((AMP)).
 


 

In actual fact, AMP Wealth is set for a solid 2013 result, Morgan Stanley suggests. AMP’s major problem in recent years has been that of its wealth protection business. A profit warning based on a downgrade to the embedded value of this business is evident in the chart above at the point the AMP and the ASX 200 parted company.

Back in early January, BA-Merrill Lynch marked AMP’s investments to market and to updated currency assumptions but despite the stock market surge, Merrills’ changes only amounted to net earnings forecast improvement of less than 1%. “We should be more constructive,” the analysts said in their report at the time, but…”

The analysts thought they and the market should by then have been more constructive on AMP given historic underperformance and solid leverage to further market upside. The big “but” was that no one outside the company could form an educated view as to the appropriateness of management’s Life Insurance valuation and the risks therein, as far as Merrills was concerned, and that AMP was yet to deliver on ambitions of earnings growth. It was beholden upon the company to provide investors sufficient detail such that they could gain confidence in future Life Insurance earnings prospects, Merrills wailed, while leaving its rating at Neutral.

Later in the month, Citi, acknowledged AMP’s 2013 result in wealth protection will likely be a weak one. Last year should have marked a bottom, nevertheless, with Citi and the market forecasting steady improvement in divisional profitability to 2015. Citi is actually above consensus, but has also questioned AMP’s disclosure policy. “At the moment,” the analysts noted, “the market seems to be struggling to believe the recovery, and transparency is certainly lacking”.

Citi believes it “reasonably likely” the big adjustments in wealth protection valuation have now been made, and strengthening is a “clear possibility”. AMP’s result release (February 20) should bring greater clarity but is “unlikely to eliminate all uncertainty”. Citi thus stuck to a Neutral rating.

Last week Macquarie noted material rate increases are occurring in AMP’s group Life premiums and individual Life premiums are also selectively being increased, but that “the sector issues are not behind us”. Structural issues are difficult to address, Macquarie noted, lapse rates are still elevated, claims trends are not improving, back-book claims will continue to develop and cyclical risks, such as rising unemployment, remain.

Quite a horror story really. And on that note, the broker upgraded from Underperform to Neutral.

As Macquarie’s litany of issues attests, AMP is not out of the woods, but at a 16% forward price/earnings discount to wealth management peer IOOF Holdings ((IFL)), based on the halving of wealth protection business earnings, the analysts basically think the market’s valuation is now fair.

JP Morgan also acknowledges AMP de-rated in 2013 due to problems in wealth protection but points out over-inflated growth expectations and dilution from capital ratings hurt earnings per share as well. The broker believes earnings volatility will continue in 2014 but also believes the stock may begin to look attractive pending some positive changes in wealth protection towards year-end.

The pain felt in the wealth protection industry in general will bring about structural changes, JP Morgan predicts, towards the end of 2014. Cash flow will improve under such changes before earnings improve, but cost reductions in other divisions can provide some earnings improvement even as revenues remain muted, say the analysts. “The stock may re-rate in such an environment.”

JP Morgan nevertheless retains Neutral. The broker rates stocks on a sector-relative basis, and sees better value elsewhere in the sector.

JP Morgan also raises the issue of the new CEO. The broker implies it’s not always best to jump into a stock until a new leader has settled in. Citi concurs, noting that whenever there is a new CEO at a company there is always a risk of some surprises. However the risk should be mitigated in this instance given the new CEO has been internally promoted and was already in charge of much of the business anyway, Citi points out.

[The risk inherent in a new CEO stems from an age-old practice of immediately slashing guidance or writing down valuations so as to provide more upside risk than downside risk in initial perceived performance, whether those downgrades are warranted or not.]

Morgan Stanley agrees with Citi that Craig Mellor is unlikely to spring any surprises given he previously oversaw the AMPCI operations. Indeed, Morgan Stanley has an Overweight (Buy equivalent) rating on AMP. None of the eight FNArena database brokers are as generous, with seven on Hold or equivalents and one (UBS) on Sell.

Morgan Stanley believes the risk/reward balance on AMP is now attractive given the stock is trading below embedded value which, in AMP’s case, rarely happens. The analysts believe all the Life risks discussed above are already thus reflected in the price and the market is ascribing no enterprise value to future business at a time AMP Wealth is set to record a solid 2013 result.

The analysts expect positive retail inflows to continue and that the 2013 margin will surprise the market, with cost control also strong. And Morgan Stanley expects 50% growth in self-managed superannuation funds (SMSF) under AMP administration (to north of 15,000).

AMP may thus be worth a punt. If you like a punt that is. It should also be noted that while AMP might see a rebound in its Life Insurance earnings, its Wealth Management earnings are leveraged to market performance, which itself can be replicated with an ETF. AMP has both customers and shareholders, both of whom expect a return. But Peter and Paul’s returns both come from the same source so one must be robbed to pay the other.
 

Technical limitations

If you are reading this story through a third party distribution channel and you cannot see charts included, we apologise, but technical limitations are to blame.

Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.